{"id":807,"date":"2026-06-30T10:00:24","date_gmt":"2026-06-30T10:00:24","guid":{"rendered":"https:\/\/fecundis.com\/?p=807"},"modified":"2026-07-02T22:22:58","modified_gmt":"2026-07-02T22:22:58","slug":"hypersperm-clinical-study-ivf-embryo-quality","status":"publish","type":"post","link":"https:\/\/fecundis.com\/es\/hypersperm-clinical-study-ivf-embryo-quality\/","title":{"rendered":"Nuevas evidencias cl\u00ednicas demuestran que HyperSperm\u2122 mejora el rendimiento de blastocistos y la calidad embrionaria en la FIV."},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Fecundis ha alcanzado un hito cient\u00edfico importante con la publicaci\u00f3n de un nuevo estudio cl\u00ednico en el <\/span><i><span style=\"font-weight: 400;\">Journal of Translational Medicine<\/span><\/i><span style=\"font-weight: 400;\">, lo que demuestra que HyperSperm\u2122 mejora los resultados clave del desarrollo embrionario en pacientes sometidas a fertilizaci\u00f3n in vitro.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">El estudio prospectivo multic\u00e9ntrico, realizado en Argentina en colaboraci\u00f3n con 3 cl\u00ednicas de fertilidad \u2014Pregna, Fertya e In Vitro Buenos Aires\u2014 evalu\u00f3 HyperSperm en 41 pacientes de FIV utilizando un dise\u00f1o de ovocitos de hermanos.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Este tipo de estudio es particularmente relevante en la reproducci\u00f3n asistida, ya que los ovocitos de una misma paciente se dividen en dos grupos. En este caso, una parte de los ovocitos se insemin\u00f3 con espermatozoides preparados mediante procedimientos de laboratorio est\u00e1ndar, mientras que la otra parte se insemin\u00f3 con espermatozoides preparados mediante el protocolo HyperSperm. Este dise\u00f1o ayuda a reducir la variabilidad entre pacientes y permite una comparaci\u00f3n m\u00e1s directa entre ambos m\u00e9todos de preparaci\u00f3n de espermatozoides.<\/span><\/p>\n<h2><b>Por qu\u00e9 la preparaci\u00f3n del esperma es importante en la FIV<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">En la reproducci\u00f3n asistida, la evaluaci\u00f3n de los espermatozoides se ha centrado tradicionalmente en la concentraci\u00f3n, la motilidad y la morfolog\u00eda. Si bien estos par\u00e1metros son esenciales, no describen completamente si un espermatozoide est\u00e1 funcionalmente preparado para fertilizar el ovocito y sustentar el desarrollo embrionario.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Antes de que se produzca la fecundaci\u00f3n de forma natural, los espermatozoides experimentan un complejo proceso biol\u00f3gico conocido como capacitaci\u00f3n. Durante este proceso, los espermatozoides adquieren la capacidad funcional necesaria para interactuar con el ovocito. Sin embargo, los m\u00e9todos convencionales de preparaci\u00f3n de espermatozoides para la FIV recuperan principalmente espermatozoides m\u00f3viles y no reproducen completamente el entorno din\u00e1mico del tracto reproductivo femenino.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">HyperSperm se desarroll\u00f3 para solucionar este problema. En lugar de limitarse a seleccionar espermatozoides, esta tecnolog\u00eda est\u00e1 dise\u00f1ada para optimizar su funci\u00f3n recreando etapas clave de la capacitaci\u00f3n previa a la fecundaci\u00f3n.<\/span><\/p>\n<h2><b>Principales hallazgos del estudio cl\u00ednico<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">El estudio demostr\u00f3 que HyperSperm aument\u00f3 el desarrollo de blastocistos en comparaci\u00f3n con la preparaci\u00f3n esperm\u00e1tica est\u00e1ndar.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Los resultados clave incluyen:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Mayor tasa de desarrollo de blastocistos: 55,6 % con HyperSperm frente a 47,9 % con la preparaci\u00f3n est\u00e1ndar.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Mayor tasa de blastocistos utilizables: 48,9 % con HyperSperm frente a 40,1 % con la preparaci\u00f3n est\u00e1ndar.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">En 5 casos en los que el grupo de control no produjo blastocistos, el grupo tratado con HyperSperm gener\u00f3 al menos un blastocisto.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">En el subgrupo de embriones analizados mediante PGT-A, se observ\u00f3 una mayor proporci\u00f3n de embriones euploides en el grupo HyperSperm.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Hasta la fecha, han nacido 11 beb\u00e9s tras el uso de HyperSperm, sin que se hayan reportado anomal\u00edas, lo que respalda a\u00fan m\u00e1s el perfil de seguridad observado hasta el momento.\u00a0<\/span><\/p>\n<h2><b>M\u00e1s embriones, m\u00e1s opciones cl\u00ednicas<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">En la FIV, cada blastocisto viable es importante. Un mayor n\u00famero de embriones con potencial para transferencia o criopreservaci\u00f3n puede ampliar las opciones cl\u00ednicas disponibles en un solo ciclo de tratamiento.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Esto es especialmente relevante para pacientes que obtienen pocos embriones o que, por cualquier otro motivo, finalizan un ciclo sin un blastocisto transferible. En este contexto, mejorar la preparaci\u00f3n del espermatozoide antes de la fecundaci\u00f3n puede tener un impacto significativo en la eficiencia de los protocolos de FIV y en el n\u00famero de oportunidades disponibles para las pacientes.<\/span><\/p>\n<h2><b>Un cambio central: la optimizaci\u00f3n de los espermatozoides<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">La publicaci\u00f3n de este estudio refuerza el enfoque cient\u00edfico de Fecundis: ir m\u00e1s all\u00e1 de la recuperaci\u00f3n convencional de espermatozoides y avanzar hacia la optimizaci\u00f3n de la funci\u00f3n esperm\u00e1tica.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Si bien muchas tecnolog\u00edas de preparaci\u00f3n de esperma se centran en seleccionar el mejor espermatozoide de una muestra, HyperSperm se basa en un concepto diferente: apoyar los procesos biol\u00f3gicos que los espermatozoides necesitan para adquirir competencia funcional antes de la fecundaci\u00f3n.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Estos hallazgos se suman a la creciente evidencia de que la fisiolog\u00eda del espermatozoide desempe\u00f1a un papel activo en el desarrollo embrionario temprano. Asimismo, respaldan la idea de que la biolog\u00eda avanzada del espermatozoide puede convertirse en un importante motor de innovaci\u00f3n en los laboratorios de FIV.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Para Fecundis, esta publicaci\u00f3n supone un paso estrat\u00e9gico en el desarrollo de HyperSperm y refuerza la posici\u00f3n de la empresa como compa\u00f1\u00eda de biotecnolog\u00eda centrada en la mejora de la reproducci\u00f3n asistida mediante tecnolog\u00edas basadas en s\u00f3lidos fundamentos cientificos.<\/span><\/p>\n<h2><b>Referencia<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Oscoz-Susino N. y otros. <\/span><i><span style=\"font-weight: 400;\">A multicenter, prospective sibling oocyte study revealed that HyperSperm\u2122 improves the number and quality of embryos in patients undergoing in vitro fertilization<\/span><\/i><span style=\"font-weight: 400;\">. Journal of Translational Medicine. 2026.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Fuente: <a href=\"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08261-4\">https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08261-4<\/a><\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Un nuevo estudio cl\u00ednico multic\u00e9ntrico publicado en Journal of Translational Medicine muestra que HyperSperm mejora el n\u00famero de blastocistos y la calidad de los embriones en pacientes de FIV.<\/p>","protected":false},"author":3,"featured_media":818,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[10],"class_list":["post-807","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-science","tag-article"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>HyperSperm Clinical Study Shows Improved Embryo Quality in IVF<\/title>\n<meta name=\"description\" content=\"New clinical evidence shows HyperSperm increased blastocyst yield and usable embryos in IVF, supporting the role of sperm capacitation in embryo development.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fecundis.com\/es\/hypersperm-clinical-study-ivf-embryo-quality\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HyperSperm Clinical Study Shows Improved Embryo Quality in IVF\" \/>\n<meta property=\"og:description\" content=\"New clinical evidence shows HyperSperm increased blastocyst yield and usable embryos in IVF, supporting the role of sperm capacitation in embryo development.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fecundis.com\/es\/hypersperm-clinical-study-ivf-embryo-quality\/\" \/>\n<meta property=\"og:site_name\" content=\"Fecundis\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-30T10:00:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-02T22:22:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fecundis.com\/wp-content\/uploads\/2026\/06\/3-fecundis-3-e1783015979895.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"633\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fran Lobbosco\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fran Lobbosco\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/\"},\"author\":{\"name\":\"Fran Lobbosco\",\"@id\":\"https:\\\/\\\/fecundis.com\\\/#\\\/schema\\\/person\\\/f41edd2dcd27cb93d795a45ebf475667\"},\"headline\":\"New Clinical Evidence Shows HyperSperm\u2122 Improves Blastocyst Yield and Embryo Quality in IVF\",\"datePublished\":\"2026-06-30T10:00:24+00:00\",\"dateModified\":\"2026-07-02T22:22:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/\"},\"wordCount\":626,\"publisher\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fecundis.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/3-fecundis-3-e1783015979895.jpg\",\"keywords\":[\"Article\"],\"articleSection\":[\"Science\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/\",\"url\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/\",\"name\":\"HyperSperm Clinical Study Shows Improved Embryo Quality in IVF\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fecundis.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/3-fecundis-3-e1783015979895.jpg\",\"datePublished\":\"2026-06-30T10:00:24+00:00\",\"dateModified\":\"2026-07-02T22:22:58+00:00\",\"description\":\"New clinical evidence shows HyperSperm increased blastocyst yield and usable embryos in IVF, supporting the role of sperm capacitation in embryo development.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fecundis.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/3-fecundis-3-e1783015979895.jpg\",\"contentUrl\":\"https:\\\/\\\/fecundis.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/3-fecundis-3-e1783015979895.jpg\",\"width\":2000,\"height\":633,\"caption\":\"The Fecundis team at the Barcelona Science Park, advancing the scientific development of HyperSperm\u2122 and new solutions to improve IVF outcomes.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fecundis.com\\\/hypersperm-clinical-study-ivf-embryo-quality\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fecundis.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Clinical Evidence Shows HyperSperm\u2122 Improves Blastocyst Yield and Embryo Quality in IVF\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fecundis.com\\\/#website\",\"url\":\"https:\\\/\\\/fecundis.com\\\/\",\"name\":\"Fecundis\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fecundis.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fecundis.com\\\/#organization\",\"name\":\"Fecundis\",\"url\":\"https:\\\/\\\/fecundis.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/fecundis.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fecundis.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/fecundis-logo.svg\",\"contentUrl\":\"https:\\\/\\\/fecundis.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/fecundis-logo.svg\",\"width\":580,\"height\":153,\"caption\":\"Fecundis\"},\"image\":{\"@id\":\"https:\\\/\\\/fecundis.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/fecundis-lab\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fecundis.com\\\/#\\\/schema\\\/person\\\/f41edd2dcd27cb93d795a45ebf475667\",\"name\":\"Fran Lobbosco\",\"url\":\"https:\\\/\\\/fecundis.com\\\/es\\\/author\\\/fran\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HyperSperm Clinical Study Shows Improved Embryo Quality in IVF","description":"New clinical evidence shows HyperSperm increased blastocyst yield and usable embryos in IVF, supporting the role of sperm capacitation in embryo development.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fecundis.com\/es\/hypersperm-clinical-study-ivf-embryo-quality\/","og_locale":"es_ES","og_type":"article","og_title":"HyperSperm Clinical Study Shows Improved Embryo Quality in IVF","og_description":"New clinical evidence shows HyperSperm increased blastocyst yield and usable embryos in IVF, supporting the role of sperm capacitation in embryo development.","og_url":"https:\/\/fecundis.com\/es\/hypersperm-clinical-study-ivf-embryo-quality\/","og_site_name":"Fecundis","article_published_time":"2026-06-30T10:00:24+00:00","article_modified_time":"2026-07-02T22:22:58+00:00","og_image":[{"width":2000,"height":633,"url":"https:\/\/fecundis.com\/wp-content\/uploads\/2026\/06\/3-fecundis-3-e1783015979895.jpg","type":"image\/jpeg"}],"author":"Fran Lobbosco","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Fran Lobbosco","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/#article","isPartOf":{"@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/"},"author":{"name":"Fran Lobbosco","@id":"https:\/\/fecundis.com\/#\/schema\/person\/f41edd2dcd27cb93d795a45ebf475667"},"headline":"New Clinical Evidence Shows HyperSperm\u2122 Improves Blastocyst Yield and Embryo Quality in IVF","datePublished":"2026-06-30T10:00:24+00:00","dateModified":"2026-07-02T22:22:58+00:00","mainEntityOfPage":{"@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/"},"wordCount":626,"publisher":{"@id":"https:\/\/fecundis.com\/#organization"},"image":{"@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/#primaryimage"},"thumbnailUrl":"https:\/\/fecundis.com\/wp-content\/uploads\/2026\/06\/3-fecundis-3-e1783015979895.jpg","keywords":["Article"],"articleSection":["Science"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/","url":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/","name":"HyperSperm Clinical Study Shows Improved Embryo Quality in IVF","isPartOf":{"@id":"https:\/\/fecundis.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/#primaryimage"},"image":{"@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/#primaryimage"},"thumbnailUrl":"https:\/\/fecundis.com\/wp-content\/uploads\/2026\/06\/3-fecundis-3-e1783015979895.jpg","datePublished":"2026-06-30T10:00:24+00:00","dateModified":"2026-07-02T22:22:58+00:00","description":"New clinical evidence shows HyperSperm increased blastocyst yield and usable embryos in IVF, supporting the role of sperm capacitation in embryo development.","breadcrumb":{"@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/#primaryimage","url":"https:\/\/fecundis.com\/wp-content\/uploads\/2026\/06\/3-fecundis-3-e1783015979895.jpg","contentUrl":"https:\/\/fecundis.com\/wp-content\/uploads\/2026\/06\/3-fecundis-3-e1783015979895.jpg","width":2000,"height":633,"caption":"The Fecundis team at the Barcelona Science Park, advancing the scientific development of HyperSperm\u2122 and new solutions to improve IVF outcomes."},{"@type":"BreadcrumbList","@id":"https:\/\/fecundis.com\/hypersperm-clinical-study-ivf-embryo-quality\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fecundis.com\/"},{"@type":"ListItem","position":2,"name":"New Clinical Evidence Shows HyperSperm\u2122 Improves Blastocyst Yield and Embryo Quality in IVF"}]},{"@type":"WebSite","@id":"https:\/\/fecundis.com\/#website","url":"https:\/\/fecundis.com\/","name":"Fecundis","description":"","publisher":{"@id":"https:\/\/fecundis.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fecundis.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/fecundis.com\/#organization","name":"Fecundis","url":"https:\/\/fecundis.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/fecundis.com\/#\/schema\/logo\/image\/","url":"https:\/\/fecundis.com\/wp-content\/uploads\/2026\/04\/fecundis-logo.svg","contentUrl":"https:\/\/fecundis.com\/wp-content\/uploads\/2026\/04\/fecundis-logo.svg","width":580,"height":153,"caption":"Fecundis"},"image":{"@id":"https:\/\/fecundis.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/fecundis-lab\/"]},{"@type":"Person","@id":"https:\/\/fecundis.com\/#\/schema\/person\/f41edd2dcd27cb93d795a45ebf475667","name":"Fran Lobbosco","url":"https:\/\/fecundis.com\/es\/author\/fran\/"}]}},"_links":{"self":[{"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/posts\/807","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/comments?post=807"}],"version-history":[{"count":2,"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/posts\/807\/revisions"}],"predecessor-version":[{"id":820,"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/posts\/807\/revisions\/820"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/media\/818"}],"wp:attachment":[{"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/media?parent=807"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/categories?post=807"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fecundis.com\/es\/wp-json\/wp\/v2\/tags?post=807"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}